A7J8L3 (A7J8L3_SARS) Severe acute respiratory syndrome coronavirus (SARS-CoV)
Polyprotein orf1a UniProtKBInterProInteractive Modelling
4382 aa; Sequence (Fasta) ;
14 identical sequences
It is possible new templates exist for this target since these models were created.
Available Structures
63 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of SARS-CoV papain-like protease C112S mutant in complex with ubiquitin |
Heteromer P0C6U8; P62992; | 1×ZN; 1×NA; 2×NHE; 3×GOL; | ||||
| Assess | ||||||
| Crystal structure of SARS-CoV macrodomain II in complex with human Paip1 |
Heteromer P0C6U8; Q9H074; | |||||
| Assess | ||||||
| Crystal structure of nsp10/nsp16 complex of SARS coronavirus |
Heteromer P0C6U8; P0C6X7; | 1×SAM; 2×ZN; | ||||
| Assess | ||||||
| SARS-Coronavirus NSP12 bound to NSP7 and NSP8 co-factors |
Heteromer P0C6U8; P0C6X7; | 2×ZN; | ||||
| Assess | ||||||
| CryoEM structure of DNA Polymerase alpha - primase bound to SARS CoV nsp1 |
Heteromer P09884; P0C6U8; P49642; P49643; Q14181; | 3×ZN; 1×SF4; | ||||
| Assess | ||||||
| SARS-Coronavirus NSP12 bound to NSP8 co-factor |
Heteromer P0C6U8; P0C6X7; | 2×ZN; | ||||
| Assess | ||||||
| C-terminal domain of SARS-CoV nsp8 complex with nsp7 |
Heteromer P0C6U8; P0C6X7; | |||||
| Assess | ||||||
| Crystal structure of the SARS coronavirus nsp10 at 2.1A | homo-12-mer | 24×ZN; | ||||
| Assess | ||||||
| The crystal structure of SARS nsp10 without zinc ion as additive | homo-12-mer | 24×ZN; | ||||
| Assess | ||||||
| SARS-CoV-1 3CLPro in complex with N-(4-(1H-imidazol-4-yl)phenyl)-2-(1H-benzo[d][1,2,3]triazol-1-yl)… | homo-2-mer | 4×GOL; 2×Y6G; 2×PEG; | ||||
| Assess | ||||||
| X-ray Structure of SARS-CoV main protease covalently modified by compound GRL-0686 | homo-2-mer | 2×4IO; 10×DMS; | ||||
| Assess | ||||||
| SARS-CoV-1 3CLPro in complex with 2-(1H-benzo[d][1,2,3]triazol-1-yl)-N-(3-chlorobenzyl)-N-(4-(2-oxo… | homo-2-mer | 4×PEG; 6×GOL; 2×Y67; | ||||
| Assess | ||||||
| SARS-CoV-1 3CLPro in complex with N-(4-(1H-pyrazol-4-yl)phenyl)-2-(1H-benzo[d][1,2,3]triazol-1-yl)-… | homo-2-mer | 4×GOL; 2×Y6A; | ||||
| Assess | ||||||
| SARS-CoV-1 3CLPro in complex with 2-(1H-benzo[d][1,2,3]triazol-1-yl)-N-(4-(pyridin-3-yl)phenyl)-N-(… | homo-2-mer | 2×Y6D; 4×GOL; | ||||
| Assess | ||||||
| Crystal structure of the complex resulting from the reaction between the SARS-CoV main protease and… | homo-2-mer | 2×OEW; 2×DMS; | ||||
| Assess | ||||||
| Crystal structure of SARS-CoV 3C-like protease with C4Z | homo-2-mer | 3×EDO; | ||||
| Assess | ||||||
| Crystal structure of SARS-CoV 3C-like protease with M4Z | homo-2-mer | 3×EDO; 1×GOL; | ||||
| Assess | ||||||
| Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease in Complex with N-[(1R)-2-(te… | homo-2-mer | 2×0EN; 4×DMS; | ||||
| Assess | ||||||
| Crystal structure of SARS coronavirus main protease complexed with Cm-FF-H (soaking) | homo-2-mer | 2×S89; | ||||
| Assess | ||||||
| Crystal structure of SARS-CoV 3C-like protease with B4Z | homo-2-mer | 8×EDO; 1×GOL; | ||||
| Assess | ||||||
| Crystal structure of SARS-CoV 3C-like protease in apo form | homo-2-mer | 1×PEG; 7×EDO; | ||||
| Assess | ||||||
| Structure of SARS 3CL protease with peptidic aldehyde inhibitor | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of SARS-CoV 3C-like protease with C6Z | homo-2-mer | 1×EDO; | ||||
| Assess | ||||||
| SARA CoV-2 3C-like protease in complex with GSK3487016A | homo-2-mer | 2×WYR; 4×EDO; | ||||
| Assess | ||||||
| Covalent complex of SARS-CoV main protease with 4-methoxy-N-[(2S)-4-methyl-1-oxo-1-({(2S)-3-oxo-1-[… | homo-2-mer | 2×V3D; 1×EDO; | ||||
| Assess | ||||||
| Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute … | homo-2-mer | 2×23H; 4×DMS; | ||||
| Assess | ||||||
| 1.65 A resolution structure of SARS-CoV 3CL protease in complex with inhibitor 7j | homo-2-mer | 2×VDJ; 2×QYS; | ||||
| Assess | ||||||
| Structure of the SARS-CoV-1 main protease in complex with AG7404 | homo-2-mer | 2×XNV; | ||||
| Assess | ||||||
| Covalent complex of SARS-CoV main protease with N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrr… | homo-2-mer | 2×V2M; | ||||
| Assess | ||||||
| 1.70 A resolution structure of SARS-CoV 3CL protease in complex with a deuterated GC376 alpha-ketoa… | homo-2-mer | 2×CL; 2×VR4; 1×PG4; | ||||
| Assess | ||||||
| X-Ray Crystal Structure of the SARS Coronavirus Main Protease | homo-2-mer | 1×MPD; | ||||
| Assess | ||||||
| Structure of SARS 3CL protease auto-proteolysis resistant mutant in the absent of inhibitor | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of dimeric R298A mutant of SARS coronavirus main protease | homo-2-mer | |||||
| Assess | ||||||
| Covalent complex of SARS-CoV main protease with ethyl (4R)-4-({N-[(4-methoxy-1H-indol-2-yl)carbonyl… | homo-2-mer | 1×EDO; 2×V34; | ||||
| Assess | ||||||
| 1.85 A resolution structure of SARS-CoV 3CL protease in complex with deuterated GC376 | homo-2-mer | 2×K36; 2×B1S; | ||||
| Assess | ||||||
| Structure-Based Design, Synthesis, Evaluation of Peptide-mimetic SARS 3CL Protease Inhibitors | homo-2-mer | |||||
| Assess | ||||||
| Crystal Structure of the F140A mutant of SARS-Coronovirus 3C-like Protease at pH 6.5 | homo-2-mer | |||||
| Assess | ||||||
| Crystal Structure of the F140A mutant of SARS-Coronovirus 3C-like Protease at pH 7.6 | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of SARS coronavirus main protease in complex with PF07304814 | homo-2-mer | 2×80I; | ||||
| Assess | ||||||
| Crystal Structure of the F140A mutant of SARS-Coronovirus 3C-like Protease at pH 6.0 | homo-2-mer | |||||
| Assess | ||||||
| Mutation of Asn28 disrupts the enzymatic activity and dimerization of SARS 3CLpro | homo-2-mer | |||||
| Assess | ||||||
| Crystal structure of SARS main protease in complex with inhibitor YH-53 | homo-2-mer | 2×HUR; | ||||
| Assess | ||||||
| Crystal structure of SARS main protease in complex with GC376 | homo-2-mer | 2×UED; | ||||
| Assess | ||||||
| Crystal structure of SARS coronavirus main protease in complex with an inhibitor Shikonin | homo-2-mer | 1×FNO; | ||||
| Assess | ||||||
| Human SARS coronavirus unique domain | homo-2-mer | 2×SO4; | ||||
| Assess | ||||||
| Crystal Structure of SARS-CoV nsp9 G104E | homo-2-mer | 4×PO4; 7×GOL; | ||||
| Assess | ||||||
| Crystal structure of SARS coronavirus papain-like protease conjugated with beta-mercaptoethanol | monomer | 1×ZN; 1×BME; 5×NA; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of SARS coronavirus papain-like protease in complex with glycerol | monomer | 1×ZN; 5×NA; 3×GOL; | ||||
| Assess | ||||||
| A new class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication | monomer | 1×TTT; 1×ZN; 2×CL; | ||||
| Assess | ||||||
| X-Ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of… | monomer | 1×ZN; 1×S88; 2×DMS; 1×GOL; | ||||
| Assess | ||||||
| Severe Acute Respiratory Syndrome-Coronavirus Papain-Like Protease Inhibitors: Design, Synthesis, P… | monomer | 1×GRM; 1×ZN; | ||||
| Assess | ||||||
| The co-crystal structure of Severe Acute Respiratory Syndrome Coronavirus 3C Like Protease with ald… | monomer | 1×EOF; | ||||
| Assess | ||||||
| The co-crystal structure of Severe Acute Respiratory Syndrome Coronavirus 3C-Like Protease with ald… | monomer | 1×EOC; | ||||
| Assess | ||||||
| X-Ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of… | monomer | 1×ZN; 1×P85; 1×DMS; | ||||
| Assess | ||||||
| Structure of SARS 3CL protease with peptidic aldehyde inhibitor containing cyclohexyl side chain | monomer | |||||
| Assess | ||||||
| Crystal Structure of the S139A mutant of SARS-Coronovirus 3C-like Protease | monomer | |||||
| Assess | ||||||
| SARS coronavirus-unique domain (SUD): Three-domain molecular architecture in solution and RNA bindi… | monomer | |||||
| Assess | ||||||
| Crystal structure of NSP10 from Sars coronavirus | monomer | 2×ZN; 1×GOL; | ||||
| Assess | ||||||
| NMR solution structure of C-terminal domain of SARS-CoV main protease in 2.5M urea | monomer | |||||
| Assess | ||||||
| NMR STRUCTURE OF A PUTATIVE RNA BINDING PROTEIN (SARS1) FROM SARS CORONAVIRUS | monomer | |||||
| Assess | ||||||
| NMR Structure of the SARS Coronavirus Nonstructural Protein Nsp7 in Solution at pH 6.5 | monomer | |||||
| Assess | ||||||
| SARS coronavirus-unique domain (SUD): Three-domain molecular architecture in solution and RNA bindi… | monomer | |||||
| Assess | ||||||
| Solution structure of the SARS-unique domain-C from the nonstructural protein 3 (nsp3) of the sever… | monomer | |||||
| Assess | ||||||
6 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3e9s.1.A | monomer | 0.76 | 1×TTT; 1×ZN; | 100.00 | ||
| Assess | ||||||
| 5b6o.1.B | monomer | 0.76 | 99.68 | |||
| Assess | ||||||
| 7fac.1.A | monomer | 0.76 | 2×ZN; | 100.00 | ||
| Assess | ||||||
| 8f2e.1.A | monomer | 0.75 | 88.11 | |||
| Assess | ||||||
| 8ufl.1.A | monomer | 0.73 | 100.00 | |||
| Assess | ||||||
| 7msw.1.A | monomer | 0.71 | 2×ZN; | 68.34 | ||
| Assess | ||||||